Costs and healthcare utilisation of patients with heart failure in Spain.
Carlos EscobarLuis VarelaBeatriz PalaciosMargarita CapelAntoni SicrasAram SicrasAntonio HormigoRoberto AlcázarNicolás ManitoManuel BotanaPublished in: BMC health services research (2020)
During the 2015-2019 period, costs of HF patients in Spain were substantial, being HF hospitalizations the most important determinant. Medication costs represented only a small proportion of total costs. Improving HF management, particularly through the use of drugs that reduce HF hospitalization may be helpful to reduce HF burden.